Bachelors in Life Science. 1 year research experience. Project titled Out of Pocket Expenditure for Esophageal cancer treatment : A multicentric study in Northeast India.
Experience in a reputed R&D institute in the areas of food analysis using modern analytical instruments, method validation, food product development and having computer knowledge in MS-office tools will be preferred.
Ph.D. in Biotechnology / Life Sciences with a strong publication record. Candidate must have very strong experience in molecular cloning, mutagenesis, protein expression, purifications, and biomolecular characterization.
A M.Sc degree in Chemistry/Zoology or an equivalent degree and at least two years of post-M.Sc research experience as evidenced from the published papers in standard referred journals
Establish and lead the downstream group within the Biological Drug Substance Unit with process and operations-based expertise to support delivery of developed purification processes and of clinical batches of purified recombinant proteins
Hetero is one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector.
1 to 2 year experience in pharmaceuticals company for operation and cleaning of Glatt integrated line (Horizontal)/Octagonal Blender/Bin Blender/Sifter/Mill operation and cleaning Fette Compression machine/Capsule filling machine
In a compelling interview with Genomic Press, published today in Genomic Psychiatry, Dr. Miguel E. Rentería reveals how his journey from Mexico to becoming one of Australias most influential neuroscientists exemplifies the transformative power of curiosity, determination, and global scientific collaboration.
In its 25th meeting held on 06.08.2025 at CDSCO Headquarters, New Delhi, the Subject Expert Committee (SEC) on Oncology recommended approval for Dr. Reddy’s Laboratories to import and market Olutasidenib Capsules.
US Food and Drug Administration (FDA) approved olutasidenib capsules for adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible IDH1 mutation as detected by an FDA-approved test.
CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd., has obtained marketing authorisation from UK’s Medicines and Healthcare products Regulatory Agency for Dazublys, its trastuzumab biosimilar version.
Passed B.Pharm degree from a statutory university. Registration Certificate of State Pharmacy Council Valid registration certificate as per State Pharmacy Act, 1948 is required.
Masters / Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences / MVSc/ Animal Sciences. Doctoral Degree in Science / Pharma / MD / MS from a recognized University or equivalent.